Charlotte Harrison
@charlotteh560.bsky.social
📤 26
đź“Ą 49
đź“ť 4
Freelance science writer and editor
Targeting IL-33 could act more widely on COPD inflammatory pathways than current therapies - my latest for
@natbiotech.nature.com
rdcu.be/fld8G
loading . . .
Newcomer anti-IL-33 makes strides in COPD
Nature Biotechnology - AstraZeneca’s IL-33 antibody tozorakimab targets two distinct signaling pathways engaged in COPD: inflammation and epithelial dysfunction.
https://rdcu.be/fld8G
5 days ago
0
2
1
Researchers are increasingly using organ chips and organoids alongside or instead of animals to model drug safety, biological mechanisms and rare diseases. My latest for Lab Animal
@natureportfolio.nature.com
rdcu.be/eH7Pj
With insight from
@nc3rs.bsky.social
@emulatebio.bsky.social
and others
loading . . .
New approach methodologies gain momentum, providing human-relevant alternatives to animal models
Lab Animal - Researchers are increasingly using organ-on-chips and organoids alongside or instead of animals to model drug safety, biological mechanisms and rare diseases.
https://rdcu.be/eH7Pj
8 months ago
0
0
1
Can amylin-based drugs upstage GLP-1 agonists? They could avoid muscle loss and gastrointestinal side effects of current obesity therapies. My latest for
@natbiotech.nature.com
rdcu.be/ezwbM
loading . . .
Can amylin-based drugs upstage GLP-1 agonists?
Nature Biotechnology - Analogs of the pancreatic peptide hormone amylin are making strides in obesity as developers zoom in on oral drugs that can emulate or even improve on injectable GLP-1...
https://rdcu.be/ezwbM
10 months ago
0
8
3
reposted by
Charlotte Harrison
Nature Biotechnology
about 1 year ago
Biopharma dives into tumor-seeking radioactive drugs
www.nature.com/articles/s41...
loading . . .
Biopharma dives into tumor-seeking radioactive drugs - Nature Biotechnology
Big pharma and investors are piling into the precision radiation space as the next generation of increasingly potent targeted α-particle therapies promises to destroy cancerous cells with minimum dama...
https://www.nature.com/articles/s41587-025-02681-1
0
4
2
Hello Bluesky! Let’s try a first post…here’s my latest story for
@naturebiotech.bsky.social
on
@vertexpharma.bsky.social
non-opioid pain killer and next-gen NaV1.8 inhibitors in the pipeline
rdcu.be/ealj0
loading . . .
Vertex’s opioid-free drug for acute pain wins FDA approval
Nature Biotechnology - Society, patients and clinicians welcome a much-needed non-opioid pain medication. Vertex’s first-in-class analgesic Journavx could soon be followed by a new generation...
https://rdcu.be/ealj0
over 1 year ago
0
3
4
you reached the end!!
feeds!
log in
